Obesity Clinical Trial
— FABOfficial title:
Efficacy of the Dietary Guidelines for Americans and the Physical Activity Guidelines for Americans for Weight Control
NCT number | NCT04577547 |
Other study ID # | GFHNRC512 |
Secondary ID | |
Status | Withdrawn |
Phase | N/A |
First received | |
Last updated | |
Start date | October 2024 |
Est. completion date | December 2029 |
Verified date | January 2023 |
Source | USDA Grand Forks Human Nutrition Research Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this research is to test the effects of the Dietary and Physical Activity Guidelines for Americans on health and on eating and exercise behaviors.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | December 2029 |
Est. primary completion date | December 2029 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Obese (BMI 30.0 kg/m2 - 350 lbs [maximum weight for dual energy x-ray absorptiometry (DXA) machine]) - No contraindications to participate in exercise - hs-CRP level =3.0 and =10.0 mg/L or two consecutive measures of >10.0 mg/L measured two weeks apart - Access to high-speed internet Exclusion Criteria: - Taking chronic anti-inflammatory medications - Being pregnant, lactating, or planning to become pregnant - Diagnosed eating disorder - Taking weight loss medication - Smoking - Overt hypothyroidism - Cancer - Physical conditions that prevent safe exercise - Liking of <3 out of 10 for all available physical activity modes - Currently exercising for more than 30 minutes per day >3 days per week - Unwilling to continue with current exercise routine - Not willing to comply with all study requirements - Blood pressure greater than 140/90 |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
USDA Grand Forks Human Nutrition Research Center |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Single nucleotide polymorphisms (SNP) | Correlation of SNPs associated with skeletal muscle, catecholamine, executive function and food and exercise reinforcement | Weeks 0 | |
Other | micro RNA (miRNA) | Correlation of miRNAs associated with skeletal muscle, executive function and food and exercise reinforcement | Weeks 0, 12, 24 | |
Primary | Change in C-reactive protein (CRP) | The effect of diet and exercise on CRP | Weeks 0, 2, 4, 6, 8, 10, 12, 24 | |
Primary | Relative reinforcing value (RRV) of energy-dense snack foods | The effect of consuming a healthy DGA style or a Western style diet during weight loss and weight maintenance on the RRV of energy-dense snack food using a computer choice paradigm. For the computer choice paradigm subjects click the mouse button to play a simulated slot machine games to earn points toward receiving a portion of food or being able to do a non-food related sedentary activity (e.g., watching TV). | Weeks 0,12, 24 | |
Primary | Relative reinforcing value (RRV) of exercise | The effect of achieving the DGA recommended amounts of exercise during weight loss and weight maintenance on relative reinforcing value of exercise compared to a sedentary activity alternative using a computer choice paradigm. For the computer choice paradigm subjects click the mouse button to play a simulated slot machine games to earn points toward being able to do a chosen physical activity, such as walking on a treadmill, or a sedentary activity (e.g., watching TV). | Weeks 0,12, 24 | |
Primary | Fat and carbohydrate oxidation | The effect of diet and exercise on carbohydrate and fat oxidation in response to meals and exercise as measured by whole-room calorimetry | Weeks 0,12 | |
Secondary | Food Cognitive Interference | The effect of diet and exercise on food cognitive interference, one of the three cognitive domains of executive function, using a computerized Food Stroop test. | Weeks 0, 12, 24 | |
Secondary | Cognitive flexibility | The effect of diet and exercise on cognitive flexibility, one of the three cognitive domains of executive function, using a computerized Trail-Making test B/A. | Weeks 0, 12, 24 | |
Secondary | Working memory | The effect of diet and exercise on cognitive flexibility, one of the three cognitive domains of executive function, using the Wisconsin Card Sorting Task. | Weeks 0, 12, 24 | |
Secondary | Inflammation | The effect of diet and exercise on plasma pro-inflammatory cytokines (e.g., Il-6, MCP-1, TNF-alpha) and anti-inflammatory cytokines (e.g., IL-10, Soluble TNF receptor I and II) | Weeks 0, 2, 4, 6, 8, 10, 12, 24 | |
Secondary | Change in adipokines | The effect of diet and exercise on plasma adipokines (e.g., adiponectin, resistin) | Weeks 0, 2, 4, 6, 8, 10, 12, 24 | |
Secondary | Change in myokines | The effect of diet and exercise on plasma myokines (e.g., BDNF, Myostatin, FGF-21, Irisin) | Weeks 0, 2, 4, 6, 8, 10, 12, 24 | |
Secondary | Change in bile acids | The effect of diet and exercise on plasma bile acids (i.e., glycocholic acid, glyco-CDCA, glyco-HDCA, hyocholic acid, hyodeoxycholic acid) | Weeks 0, 2, 4, 6, 8, 10, 12, 24 | |
Secondary | Change in blood lipids | The effect of diet and exercise on cholesterol, HDL, triglycerides | Weeks 0, 2, 4, 6, 8, 10, 12, 24 | |
Secondary | Change in weight control moderators | Questionnaires (i.e., three-factor eating questionnaire, reward base eating, food attitudes and behavior survey) that when scored provide a single number will be used to determine the moderating effect of self efficacy, restraint and disinhibition maintaining diet and exercise changes | Weeks 0,12, 24 | |
Secondary | Change in humoral biomarkers of eating behavior | The effect of diet and exercise on ghrelin, leptin, thyroid hormones, gut peptides, fatty acids | Weeks 0, 2, 4, 6, 8, 10, 12, 24 | |
Secondary | Gene expression profiles of glucose oxidation | The effect of diet and exercise on gene expression profiles associated with glucose oxidation (i.e., hexokinase, phosphofructokinase, pyruvate dehydrogenase kinase 4, peroxisome proliferator-activated receptor alpha gene expression) | Weeks 0, 2, 4, 6, 8, 10, 12, 24 | |
Secondary | Gene expression profiles of fat oxidation | The effect of diet and exercise on on gene expression profiles associated with fat oxidation (i.e., fatty acid translocase, fatty acid synthase, acetyl Co-A carboxylase 2, stearoyl Co-A desaturase gene expression) | Weeks 0, 2, 4, 6, 8, 10, 12, 24 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |